Financhill
Back

Arcutis Biotherapeutics, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
72

ARQT
Arcutis Biotherapeutics, Inc.

Last Price:
$29.90
Seasonality Move:
61.76%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARQT is experiencing buying pressure, which is a positive indicator for future bullish movement.

Arcutis Biotherapeutics, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 28.75 Buy
20-day SMA: 29.79 Buy
50-day SMA: 26.03 Buy
200-day SMA: 18 Buy
8-day EMA: 28.93 Buy
20-day EMA: 28.75 Buy
50-day EMA: 26.3 Buy
200-day EMA: 19.41 Buy

Arcutis Biotherapeutics, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.67 Buy
Relative Strength Index (14 RSI): 60.13 Buy
Chaikin Money Flow: 1966901 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.99 - 30.73) Buy
Bollinger Bands (100): (16.12 - 26.92) Buy

Arcutis Biotherapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Arcutis Biotherapeutics, Inc. Stock

Is Arcutis Biotherapeutics, Inc. Stock a Buy?

ARQT Technical Analysis vs Fundamental Analysis

Buy
72
Arcutis Biotherapeutics, Inc. (ARQT) is a Buy

Is Arcutis Biotherapeutics, Inc. a Buy or a Sell?

Arcutis Biotherapeutics, Inc. Stock Info

Market Cap:
3.7B
Price in USD:
29.90
Share Volume:
2.2M

Arcutis Biotherapeutics, Inc. 52-Week Range

52-Week High:
31.77
52-Week Low:
11.13
Buy
72
Arcutis Biotherapeutics, Inc. (ARQT) is a Buy

Arcutis Biotherapeutics, Inc. Share Price Forecast

Is Arcutis Biotherapeutics, Inc. Stock a Buy?

Fundamental Analysis of Arcutis Biotherapeutics, Inc.

Is Arcutis Biotherapeutics, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.19 per share, and an increase next year of $0.60 per share.

Technical Analysis of Arcutis Biotherapeutics, Inc.

Should I short Arcutis Biotherapeutics, Inc. stock?

* Arcutis Biotherapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.